» Articles » PMID: 38981572

Peridroplet Mitochondria Are Associated with the Severity of MASLD and the Prevention of MASLD by Diethyldithiocarbamate

Overview
Journal J Lipid Res
Publisher Elsevier
Specialty Biochemistry
Date 2024 Jul 9
PMID 38981572
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria can contact lipid droplets (LDs) to form peridroplet mitochondria (PDM) which trap fatty acids in LDs by providing ATP for triglyceride synthesis and prevent lipotoxicity. However, the role of PDM in metabolic dysfunction associated steatotic liver disease (MASLD) is not clear. Here, the features of PDM in dietary MASLD models with different severity in mice were explored. Electron microscope photographs show that LDs and mitochondria rarely come into contact with each other in normal liver. In mice fed with high-fat diet, PDM can be observed in the liver as early as the beginning of steatosis in hepatocytes. For the first time, we show that PDM in mouse liver varies with the severity of MASLD. PDM and cytosolic mitochondria were isolated from the liver tissue of MASLD and analyzed by quantitative proteomics. Compared with cytosolic mitochondria, PDM have enhanced mitochondrial respiration and ATP synthesis. Diethyldithiocarbamate (DDC) alleviates choline-deficient, L-amino acid-defined diet-induced MASLD, while increases PDM in the liver. Similarly, DDC promotes the contact of mitochondria-LDs in steatotic C3A cells in vitro. Meanwhile, DDC promotes triglyceride synthesis and improves mitochondrial dysfunction in MASLD. In addition, DDC upregulates perilipin 5 both in vivo and in vitro, which is considered as a key regulator in PDM formation. Knockout of perilipin 5 inhibits the contact of mitochondria-LDs induced by DDC in C3A cells. These results demonstrate that PDM might be associated with the progression of MASLD and the prevention of MASLD by DDC.

Citing Articles

Myokines and Their Potential Protective Role Against Oxidative Stress in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Bucarey J, Trujillo-Gonzalez I, Paules E, Espinosa A Antioxidants (Basel). 2024; 13(11).

PMID: 39594505 PMC: 11591161. DOI: 10.3390/antiox13111363.

References
1.
Arruda A, Pers B, Parlakgul G, Guney E, Inouye K, Hotamisligil G . Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat Med. 2014; 20(12):1427-35. PMC: 4412031. DOI: 10.1038/nm.3735. View

2.
Gordaliza-Alaguero I, Canto C, Zorzano A . Metabolic implications of organelle-mitochondria communication. EMBO Rep. 2019; 20(9):e47928. PMC: 6726909. DOI: 10.15252/embr.201947928. View

3.
Talari N, Mattam U, Meher N, Paripati A, Mahadev K, Krishnamoorthy T . Lipid-droplet associated mitochondria promote fatty-acid oxidation through a distinct bioenergetic pattern in male Wistar rats. Nat Commun. 2023; 14(1):766. PMC: 9918515. DOI: 10.1038/s41467-023-36432-0. View

4.
Liu T, Wang P, Cong M, Zhang D, Liu L, Li H . Matrix metalloproteinase-1 induction by diethyldithiocarbamate is regulated via Akt and ERK/miR222/ETS-1 pathways in hepatic stellate cells. Biosci Rep. 2016; 36(4). PMC: 4995499. DOI: 10.1042/BSR20160111. View

5.
Liu T, Wang P, Cong M, Xu Y, Jia J, You H . The CYP2E1 inhibitor DDC up-regulates MMP-1 expression in hepatic stellate cells via an ERK1/2- and Akt-dependent mechanism. Biosci Rep. 2013; 33(3). PMC: 3673035. DOI: 10.1042/BSR20130033. View